REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medicantes S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medicantes S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Medicantes S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on October 11, 2012. The total number of employees is currently 4 (2021). The company’s latest financial report indicates a net sales revenue drop of 69.82% in 2022. Over the same period, its total assets grew by 42.91%. The enterprise’s net profit margin decreased by 1.2% in 2022.

Headquarters
Av Tercera 208
Guayaquil; Guayas;

Contact Details: Purchase the Medicantes S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Medicantes S.A. report to view the information.
Outstanding Shares:
Purchase the Medicantes S.A. report to view the information.
Registered Capital:
Purchase the Medicantes S.A. report to view the information.
Incorporation Date:
October 11, 2012
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
37.5%
Purchase this report to view the information.
32.5%
Purchase this report to view the information.
30%
Subsidiaries
Med & Sul S.A.
60%
Dimera S.A.
32.5%
Company Performance
Financial values in the chart are available after Medicantes S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-69.82%▼
Total operating revenue
-69.82%▼
Operating profit (EBIT)
-74.4%▼
Net Profit (Loss) for the Period
-75.39%▼
Total assets
42.91%▲
Total equity
1.11%▲
Operating Profit Margin (ROS)
-1.5%▼
Net Profit Margin
-1.2%▼
Return on Equity (ROE)
-3.4%▼
Quick Ratio
46.95%▲
Cash Ratio
46.77%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo